非酒精性脂肪性肝病新認(rèn)識(shí)與再更名

摘要：非酒精性脂肪性肝病是一種多系統(tǒng)受累的代謝性疾病，與胰島素抵抗和遺傳易感密切相關(guān)。目前非酒精性脂肪性肝病已成為我國(guó)乃至全球最常見的慢性肝病。本文就非酒精性脂肪性肝病的診斷和評(píng)估、非藥物治療、合并慢性乙型肝炎、靶向腸道菌群治療策略以及更名爭(zhēng)議等專家論壇的熱點(diǎn)話題進(jìn)行述評(píng)。關(guān)鍵詞：非酒精性脂肪性肝??； 診斷； 治療學(xué)； 命名基金項(xiàng)目：國(guó)家自然科學(xué)基金（81900507， 82170593）； 國(guó)家科技部重點(diǎn)研發(fā)計(jì)劃（2021YFC2700802）

A new understanding of nonalcoholic fatty liver disease and its rename

YANG Ruixu， FAN Jiangao. （Department of Gastroenterology， Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine， Shanghai 200092， China）

Corresponding author：FAN Jiangao， fanjiangao@xinhuamed.com.cn （ORCID：0000-0002-8618-6402 ）

Abstract：Nonalcoholic fatty liver disease （NAFLD） is a metabolic disease with multisystem involvement and is closely associated with insulin resistance and genetic susceptibility. At present， NAFLD has become the most common chronic liver disease in China and worldwide. This article reviews the hot topics of various expert forums such as the diagnosis and evaluation of NAFLD， non-drug treatment， comorbidity with chronic hepatitis B，  therapeutic strategies targeting intestinal flora and its rename of NAFLD.

Key words：Non-alcoholic Fatty Liver Disease； Diagnosis； Therapeutics; NomenclatureResearch funding：National Natural Science Foundation of China（81900507， 82170593）； National

Key Research and Development Program of China（2021YFC2700802）

非酒精性脂肪性肝?。∟AFLD）疾病譜包括非酒精性脂肪肝（NAFL）、非酒精性脂肪性肝炎（NASH）及其相關(guān)纖維化、肝硬化和肝細(xì)胞癌。（剩余12808字）